Neurocrine Biosciences
NBIX
#1454
Rank
S$15.98 B
Marketcap
$157.91
Share price
-4.18%
Change (1 day)
4.14%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : S$3.64 Billion

According to Neurocrine Biosciences 's latest financial reports the company has S$3.64 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$2.94 B28.75%
2022-12-31$S$2.28 B23.25%
2021-12-31$S$1.85 B24.67%
2020-12-31$S$1.48 B73.51%
2019-12-31$S$0.85 B30.73%
2018-12-31$S$0.65 B31.96%
2017-12-31$S$0.49 B9.22%
2016-12-31$S$0.45 B-24.1%
2015-12-31$S$0.60 B117.72%
2014-12-31$S$0.27 B80.76%
2013-12-31$S$0.15 B-19.19%
2012-12-31$S$0.18 B142.63%
2011-12-31$S$77.8 M212.25%
2010-12-31$S$24.91 M348.9%
2009-12-31$S$5.55 M-89.44%
2008-12-31$S$52.59 M-69.21%
2007-12-31$S$0.17 B-64.61%
2006-12-31$S$0.48 B-25.7%
2005-12-31$S$0.64 B1.09%
2004-12-31$S$0.64 B-3.31%
2003-12-31$S$0.66 B70.78%
2002-12-31$S$0.38 B-32.28%
2001-12-31$S$0.57 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$2.66 B-26.94%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.75 B 277.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-S$0.15 Million-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
S$19.20 B 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.14 B 123.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$124.13 B 3,304.24%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.64 B-82.32%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$48.82 Million-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA